I’ve been recently diagnosed with PPMS, and still enjoy pretty good neurologic function.
I will be starting ocrelizumab in the coming months. Is it realistic to expect remyelination therapies sometime soon? Has anyone read any clinical trials, articles, etc regarding this kind of therapies and the progress being made in regards to reducing disability?
Also, why should PPMS and RRMS be different in regards to remyelination? There must be some difference in pathogenesis, but the resulting demyelination is quite similar, right? (besides location, probably…)
I am not a scientist, of course, but I’m just interested in how this disease works… :/
Browse categories and add by clicking on them
You can remove current categories below by clicking the ‘x’.